We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...
Incyte (NASDAQ:INCY – Get Free Report) was downgraded by William Blair from an “outperform” rating to a “market perform” rating in a note issued to investors on Tuesday, Marketbeat.com reports.
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a ...
Conference call with COO Linford to discuss recent Klama/Walmart (WMT) contract will be held on March 20 at 10 am hosted by Wiliam Blair.Light ...
Emerging markets present a landscape of opportunity for equity investors despite macroeconomic headwinds. Click to read.
So while NCAA Tournament teams began preparing for their first-round opponents on Sunday night, Texas won't know who it is ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
Overall, Palantir has had a solid start to 2025. Its growth numbers look impressive, and its AI platform is gaining traction across industries. Yet not everyone is convinced. Some ...
We recently published a list of 11 Best Reddit Stocks to Invest In. In this article, we are going to take a look at where ...
A Wall Street analyst believes Palantir's (NASDAQ: PLTR) expanding artificial intelligence (AI) ecosystem, marked by major ...
Chiefs Coach and BYU grad Andy Reid was on hand to watch the Cougars fall behind 15-0. At halftime, the Houston lead was ...
William Blair downgraded Udemy (UDMY) to Market Perform from Outperform after the company announced the appointment of Hugo Sarrazin as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results